Cystic fibrosis (CF) patients suffer from a major problem of pulmonary infection by mucoid strains of Pseudomonas aeruginosa (1) . These infections are resistant to antibacterial therapy and persist despite the response of the host immune system. In the CF lung, mucoid P. aeruginosa strains synthesize an exopolysaccharide coat, which encapsulates the bacteria and is believed to play a critical role in the pathogenesis of the infection. The exopolysaccharide is alginate, a partially O-acetylated linear copolymer of D-mannuronate and L-guluronate, which are linked via p1-4 glycosidic bonds. The expression of alginate biosynthetic genes in P. aeruginosa is primarily associated with the CF-lung environment. Several alginate biosynthetic genes are clustered around the 34-min region of the P. aeruginosa chromosome with the algD gene at the upstream end. The algD promoter is activated by environmental conditions such as high osmolarity, nitrogen or phosphate starvation, and ethanol-induced membrane perturbation (2) (3) (4) . Some of these environmental conditions are similar to those encountered in the CF lung. Several proteins are known to regulate transcription from the algD promoter (5) . One of these proteins is AlgR1, which belongs to the response regulator family of the bacterial two-component signal transduction proteins. AlgR1 binds DNA, far upstream of the algD and algC (an alginate biosynthetic gene located outside the 34-min cluster) promoters and activates transcription (6) (7) (8) . AlgR2 is the kinase that undergoes autophosphorylation in the presence of ATP or GTP and transfers the acquired phosphate to AlgR1 (9, 10) . A functional AlgR2 is important for the AlgR1-mediated transcriptional activation of the algD promoter (11) . Thus, phosphorylation of AlgR1 is necessary for its functional activity.
Inhibition oftranscriptional activation ofalginate-encoding genes by nontoxic inhibitors may provide a way to prevent P. aeruginosa from synthesizing alginate in the CF lung, thereby leaving the bacterium susceptible to antibiotic therapy and the immune responses of the host. With this strategy in mind, we screened a collection of synthetic and natural compounds for the ability to inhibit the transcriptional activation of the algD promoter. Out of about 25,000 synthetic compounds screened, 15 were identified as inhibitors of algD transcription in vivo in whole cells. The majority of these compounds were also found to inhibit alginate synthesis to varying degrees. We therefore chose to further investigate the possible mechanism involved in the inhibition process. In particular, the effect of two types of inhibitors (see Fig. 1 ) on the activities of AlgR1 and AlgR2 were studied. The inhibitory effect of these compounds on the known kinases of other two-component systems was also examined. This may be especially relevant since kinase-regulated expression of virulence is known in other human infections (12) and in bacterially induced plant tumor formation (13) , as well as in important bacterial environmental responses such as chemotaxis (14) , nitrogen assimilation (15) , and sporulation (16) .
MATERIALS AND METHODS
Assays for the algD Promoter Activity. A previously constructed transcriptional fusion vector pVD2X (17) was used for studying the transcriptional activity ofthe algD promoter. The reporter gene xylE, which encodes catechol 2,3-dioxygenase, was cloned into the open reading frame of algD whose upstream DNA elements necessary for the AlgRl/ AlgR2-mediated transcriptional activation of the algD promoter were included in the insert. XylE expression was measured spectrophotometrically at 405 nm as the rate of generation of a-hydroxymuconic e-semialdehyde from catechol. Alginate-producing P. aeruginosa strain 8821 (18) , a mucoid strain isolated from the CF lung harboring pVD2X, was grown in the presence and absence of inhibitors. Catechol 2,3-dioxygenase assays were performed after 24 h of growth in tryptone/yeast extract broth supplemented with glucose to 0.3%. P. aeruginosa cell growth was unaffected by the inhibitors described at concentrations up to 50 gg/ml.
Isolation of the AlgR1-AlgR2 Protein Complex and Purification of AlgR2. The 80-kDa AlgR1-AlgR2 protein complex was isolated according to a published procedure (9, 10) . In brief, the cell-free extract from P. aeruginosa strain 8822 (a was heated at 57.50C at pH 5.0 for 30 sec, and the resulting precipitate was removed by centrifugation. The supernatant was subjected to gel-filtration chromatography using a Superose 12 FPLC column. Cell-free extract from P. aeruginosa strain 8822 was used as the source of AlgR2, which was also purified according to established procedures (10) . The crude extract was heated at 57.50C for 4 min at pH 5.0. After removing the precipitate by centrifugation, AlgR2 was purified using HPLC (Fig. 1 ) was determined in P. aeruginosa strain 8821 (a mucoid CF isolate). The algD promoter activity was measured by using xylE as the reporter gene (17) . The concentrations of the inhibitors required to inhibit xylE expression by 50% were 0.2 and 0.4 ug/ml for inhibitors A and B, respectively. Over 95% inhibition of algD promoter activity was observed at concentrations of 2.0 and 2.5 ,ug/ml of inhibitors A and B, respectively.
Inhibition of A1gR1-AlgR2 Phosphorylation. We previously reported the isolation of an 80-kDa protein complex containing AlgR1 and AlgR2, in which AlgR1 can be phosphorylated by AlgR2 (9, 10) . During this study, we attempted to phosphorylate AlgR1 in the 80-kDa complex when an inhibitor was present at a concentration of 50 ,ug/ml. The results, presented in Fig. 2 , indicate that inhibitors A and A' inhibit the phosphorylation of AlgR1, while inhibitor B does not have such a pronounced effect.
Inhibition of AlgR2 Kinase Activity. Since phosphorylation of AlgR2 is a prerequisite for that of AlgR1, we investigated the effects of the inhibitors on the autophosphorylation of AlgR2. AlgR2 was phosphorylated in the presence of A (50 .ug/ml), but not of B, the initial rate of phosphorylation was significantly reduced (data not shown).
To determine the mode of inhibition of AlgR2 phosphorylation, the effect of inhibitor A on the initial rate of net phosphorylation was assayed at different ATP and GTP concentrations. Fig. 4 shows the ratio of AlgR2-phosphate (AlgR2-P) in the presence of the inhibitor to that without the inhibitor at various concentrations ofATP or GTP. Results of this experiment indicate that as the ATP or GTP concentration is increased, the inhibitor appears to undergo a transition from being an inhibitor to an activator of net phosphorylation. It should be noted that AlgR2 was previously found capable of spontaneously losing its phosphate due to an autophosphatase activity (10) . The level of phosphorylation of AlgR2 is in effect determined by both the kinase and the phosphatase activities. Therefore, a possible explanation of the observation made in Fig. 4 is that, at a higher concen-FIG. 2. Inhibition of AlgR1 phosphorylation in the 80-kDa AlgR1-AlgR2 complex. Details of the isolation of this complex and its phosphorylation have been described (9, 10) . The tration of ATP or GTP, the inhibitor inhibits the phosphatase activity more effectively than the kinase activity while the reverse is true when the ATP or GTP concentration is low. In fact, we have observed that increased concentrations of ATP or GTP as well as MgCl2 induce dephosphorylation of AlgR2. Thus it was imperative to investigate the inhibition of dephosphorylation of AlgR2-P. ATP or GTP (0.1 or 1 ,uM) for 1 min after which the reaction was terminated by the addition of 4x SDS loading buffer. The samples were analyzed by SDS/PAGE and autoradiography. The level of AlgR2-P was measured by scanning the gel and is reported as percentage of the 32P-labeled AlgR2-P retained in the control experiment (carried out in the absence of ATP, GTP, or the inhibitor). Columns with the "-" sign represent samples without inhibitor A and those with the "+" sign represent samples in which the dephosphorylation reaction was carried out in the presence of inhibitor A at 50 ,ug/ml. induced dephosphorylation of AlgR2-P is significantly inhibited by inhibitor A, resulting in a much higher level of phosphate retention by AlgR2.
The level ofAlgR2-P has been shown to decline after 10 sec of incubation with ATP at a 5 mM MgCl2 concentration (10). However, no such loss of phosphate was observed when the MgCl2 concentration was reduced to negligible levels. Loss of phosphate from AlgR2-P is therefore highly dependent on the MgCl2 concentration. Thus, the phosphatase inhibition experiment was repeated by incubating AlgR2-P with 5 mM MgCl2. After a 1-min incubation with MgCl2 in the presence of inhibitor A, AlgR2-P retained a 2.33-fold higher level of phosphate relative to the control. These results clearly indicate that inhibitor A is not only an inhibitor of AlgR2-autophosphorylation (kinase) activity but also an inhibitor of its autophosphatase activity. It is likely that inhibitor A interacts with AlgR2 in such a way as to inhibit all its activities.
Inhibition of the DNA-Biding Activity of A4gRl. Binding of DNA by AlgR1 at the two specific sites centered at -458 and -382 (considering the position ofthe transcriptional start site as + 1) far upstream of the algD promoter is one of the crucial steps involved in the AlgRl/AlgR2-mediated transcriptional activation process (6, 7) . Since the inhibitors were screened on the basis of their ability to inhibit algD promoter activation, it was of interest to study the effect, if any, of the inhibitors on the binding of AlgR1 to its specific sites in the algD upstream DNA. The effect of these inhibitors was studied by monitoring the gel-mobility shift of 32P-labeled algD upstream DNA (containing a 14-mer AlgR1 consensus binding site; see ref. 6 ) caused by AlgR1 bound to it. As shown in Fig. 6 , inhibitor A and its analog did not appear to have any significant effect on the DNA binding properties of AlgR1. Inhibitor B, on the other hand, inhibited AlgR1 from binding any significant amount of the DNA probe, because "'98% of the probe remained unshifted. At higher concentrations of the AlgR1 protein preparation, the algD upstream (19, 20) . All of these kinases are known to autophosphorylate themselves at histidine residues and transfer the phosphate to the conserved aspartate residues of their cognate response regulators. Phosphorylation and phosphotransfer involved in these processes are therefore believed to share common mechanisms. In fact, a number of these proteins have been shown to be capable of "cross talk" between noncognate kinases and response regulators (21) . Thus we examined the effect of the inhibitor compounds on the kinase activities of CheA, NR,1, and KinA, which are the kinases involved in bacterial chemotaxis and nitrogen assimilation in Escherichia coli and sporulation in Bacillus, respectively (Fig. 7) . In the case of CheA, inhibitors A and A' showed partial inhibition (26% and 42%, respectively). However, inhibitors B and B' were relatively potent inhibitors (70%o and 89%, respectively). Inhibitor A' inhibited NR11 kinase activity by 10%1o while the effect of inhibitor A was insignificant. Interestingly, inhibitors B and B' exhibited almost complete inhibition of NRI, autophosphorylation. Likewise, in the case of KinA autophosphorylation, inhibitors B and B' showed strong inhibition while A and A' did not show any significant effect. In addition, the effect of these inhibitors on the transfer of phosphate from NRII-P to NRI and KinA-P to SpoOF (the cognate receivers of phosphate) was examined. In both cases, inhibitors B and B' abolished the phosphate transfer activity (data not shown).
DISCUSSION
Gene regulation in alginate synthesis by P. aeruginosa is a complex process involving several regulatory proteins, not all of which are well characterized. However, the role of AlgR1 as a phosphorylation-dependent transcriptional regulator of alginate gene expression is well established. Furthermore, AlgR2 has been shown to phosphorylate AlgR1, thereby modulating its regulatory activity. Results presented in this paper identify four compounds as inhibitors of these two protein activities involved in activation of the algD promoter. These inhibitors, which strongly inhibit the algD promoter activity in vivo, may help us correlate the phosphorylation/dephosphorylation of the AlgR2-AlgR1 complex and the DNA-binding activity of AlgR1 with their physiological roles in regulating alginate gene expression in P. aeruginosa. A model for the phosphorylation of the AlgR2-AlgR1 complex and the steps leading to the activation of the algD promoter via a DNA-looping mechanism is presented in Fig. 8 is also known to bind the algD upstream region, but its role in the activation of the promoter has not been directly demonstrated (24) . The P. aeruginosa analog of CRP and integration host factor as well as AlgR3 may facilitate the contact between the DNA-bound AlgR1 molecules (around positions -382 and -458) and RNA polymerase holoenzyme at the promoter region by a DNA-looping mechanism.
Proc. Natl. Acad Sci. USA 90 (1993) Proc. Natl. Acad. Sci. USA 90 (1993) may act as part of a global regulatory network (25) . Neuraminidase is believed to facilitate the adherence of P. aeruginosa to eukaryotic epithelial cell surfaces. Thus AlgR1-mediated gene activation may affect several important steps in pathogenesis including adherence and encapsulation. The inhibitors described in this paper may therefore play a broader role in preventing infections caused by pathogenic bacteria.
To study the effect of these inhibitors on other members of the kinase family of two-component bacterial signal transducing proteins, we examined the inhibition of autophosphorylation of three soluble kinases, CheA, NR1I, and KinA.
Inhibitors A and A', which inhibit AlgR2 kinase activity, do not appear to be general inhibitors of two-component bacterial kinases. This could be attributable to the unusual size and structure of AlgR2, which is not shared by other kinases. Surprisingly however, inhibitor B, which inhibits the DNAbinding activity ofAlgR1, strongly inhibits the autophosphorylation activities of CheA, NRII, and KinA. Inhibitor B, and its analog B', significantly inhibited the kinase activity of a transmembrane protein kinase, VirA (data not shown), suggesting that inhibitor B is active against membraneassociated sensor proteins as well. The low concentration of inhibitor B used in these experiments argues against its effect being nonspecific in nature. Thus, inhibitor B appears to be a general inhibitor of two-component bacterial kinases. The effect of inhibitor B on orthodox sensor kinases may have physiological significance with regard to alginate gene expression in P. aeruginosa. It is possible that at least two kinases, AlgR2 and a more orthodox kinase, are required for the AlgRl-mediated regulation of the algD promoter. Inhibitor B might inhibit transcription from the algD promoter in vivo by inhibiting not only the AlgR1-DNA interaction but also the orthodox kinase. It is noteworthy that the algD promoter activity is responsive to diverse signals such as osmolarity, nitrogen or phosphate starvation, dehydration, etc. (2) (3) (4) (5) . Further investigation may shed light on the exact correlation between the in vivo and in vitro activities of this compound.
Inhibitors A and B may be potentially useful in further understanding the mechanism of sensory response in a variety ofbacterial signal transduction systems. Unlike eukaryotic kinases or phosphatases, no inhibitors of prokaryotic kinases or phosphatases have been reported. Furthermore, since members of the two-component bacterial signal transduction proteins exhibit similarity in their mechanism of action, these inhibitors may provide a generally applicable tool to dissect and study different aspects of the twocomponent regulatory proteins in greater detail. These inhibitors might also be useful in other cases of bacterial pathogenesis involving two-component signal transduction mechanisms. 
